📰 Bioscience Inc News
Page 48 - Bioscience Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioscience Inc. Real-time updates on events, politics, business and more.
May 9, 2022
ANN ARBOR, Mich., April 28, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Stephen Rocamboli as a Class I director,...
May 9, 2022
/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...
May 7, 2022
Immatics (NASDAQ:IMTX – Get Rating) and ZIVO Bioscience (OTCMKTS:ZIVO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk. Profitability This table compares Immatics and ZIVO Bioscience’s net margins, […]
May 7, 2022
/PRNewswire/ -- The agricultural biotechnology market has been categorized under the global agricultural biotechnology market as a part of the global...
May 2, 2022
WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience...
May 1, 2022
WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience...
April 30, 2022
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 9,200 shares, a drop of 75.7% from the March 31st total of 37,800 shares. Based on an average daily trading volume, of 115,200 shares, […]
April 30, 2022
Artivion (NYSE:AORT – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Institutional and Insider Ownership 82.2% of Artivion shares are owned […]
April 28, 2022
/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...
April 28, 2022
ANN ARBOR, Mich., April 28, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Stephen Rocamboli as a Class I director,...